An Ottawa man says his insurance company is refusing to reimburse him for a brand name anti-rejection medication, even though his doctor has provided a note explaining why it is necessary. Shad Zekry, who received a kidney from his wife, had been receiving reimbursement for the drug for years until April, when the coverage was suddenly cut off.
Patient's Frustration
Zekry expressed frustration over the situation, stating that the medication is critical to prevent organ rejection. He noted that his physician has clearly documented the medical need for the brand name version over generics. Despite this, the insurance company has not budged.
Insurance Company's Stance
The insurance provider has not publicly commented on the specific case, but such denials often stem from policies that favor lower-cost generic alternatives. However, patients and doctors argue that brand name drugs may be necessary due to differences in absorption or side effects.
Zekry is now considering appealing the decision or seeking legal advice. He hopes that sharing his story will raise awareness about the challenges patients face when insurance companies deny coverage for prescribed medications.
